Trabeculectomy Technique the Moorfields Safe Surgery System with New Adjustable Sutures

Total Page:16

File Type:pdf, Size:1020Kb

Trabeculectomy Technique the Moorfields Safe Surgery System with New Adjustable Sutures SURGICAL PEARLS Trabeculectomy Technique The Moorfields Safe Surgery System with new adjustable sutures. BY PENG TEE KHAW, PHD, FRCS, FRCOPHTH, FRCP, FRCPATH, FIBIOL, FMEDSCI; ANNEGRET DAHLMANN, MD, FRCOPHTH; AND KAMIAR MIRESKANDARI, MD, FRCOPHTH his article presents a system of glaucoma surgery bleb is ultimately located under the upper lid. Otherwise, known as the Safe Surgery System that has evolved the chance of discomfort to the patient and of bleb-related at Moorfields Eye Hospital in London. The sys- complications such as leak and infection is markedly higher. T tem’s development is based on a need to improve If it is not possible to place the bleb under the patient’s the consistency of the surgery and its outcome, particularly upper lid, then we perform tube-drainage surgery instead. from the patient’s point of view. The use of strong antimetabolites such as mitomycin C TRACTION SUTURE (MMC) during trabeculectomy increases the risk of po- We always use a corneal traction suture to avoid a superi- tential complications, including hypotony with visual loss or rectus hematoma and to achieve maximal traction. Our and leaking as well as uncomfortable blebs that may lead to preference is a 7–0 black silk suture on a semicircular needle endophthalmitis. The Safe Surgery System is designed to (Figure 1). preserve visual acuity by minimizing hypotony and bleb- related complications while achieving a desirable postopera- CONJUNCTIVAL INCISION tive IOP. Table 1 highlights several ways in which the system We now only use fornix-based flaps, mainly because of the prevents complications. scleral exposure and controlled surgery they afford. This type of flap also eliminates the posterior incision of limbus-based POSITION OF FILTRATION AREA surgery that often results in a posterior restricting scar. We Our first step is carefully to assess and draw the lid’s posi- avoid radial, side-relaxing incisions. We dissect backward tion in relation to the superior limbus. We ensure that the with Westcott scissors to make a pocket approximately 10 to Figure 1. Placing a corneal traction suture averts hematoma Figure 2. The authors dissect over the rectus muscle and lift of the superior rectus muscle. the conjunctiva. 22 IGLAUCOMA TODAYIMARCH/APRIL 2005 SURGICAL PEARLS Figure 3. The ring of steel and anterior aqueous flow are visible. Figure 4. The authors cut a scleral pocket. 15 mm posteriorly and sufficiently wide to accommodate lowed a larger area of antimetabolite treatment, without the antimetabolite sponges. When dissecting over the supe- a posteriorly placed restricting scar. Similar blebs can be rior rectus tendon, we lift the conjunctiva to cut attach- achieved with a limbus-based flap, but the incision must ments while avoiding the tendon itself (Figure 2). be located quite posteriorly. Results are less consistent In the past, we relied on a limbus-based incision and an with this method, and we find it more difficult subse- antimetabolite due to our concern about postoperative quently to create the scleral flap and place sutures, par- leaks. Dr. Khaw’s clinical observation of all cystic blebs, ticularly in repeat trabeculectomies. however, led to his hypothesis that they had two things in common. The first was restricted posterior flow due to a SCLERAL FLAP ring of scar tissue, which he called the ring of steel. The sec- Our next step is to create an incision and a scleral pocket ond was a source of limbal drainage (Figure 3). The restrict- (similar to a phacoemulsification pocket), after which we cut ed flow from the posterior incision resulted in more focal, the two side incisions (Figure 4). We do not cut the side inci- cystic blebs, a finding that led us to convert to fornix-based sions right to the limbus in order to encourage posterior flow flaps. and reduce the incidence of cystic blebs. We cut the scleral With limbus-based flaps, the effects of treatment were flap before applying an antimetabolite. focal. Moreover, although their growth halted,1,2 the cells We try to make the largest flap possible. Leaving the side at the edge of the treatment area could produce scar tis- cuts at the limbus incomplete (1 to 2 mm from the limbus) sue and encapsulate the area, both of which resulted in a (Figure 5) forces the aqueous backward over a wide area to thin, cystic bleb. A fornix-based incision, by contrast, al- achieve a diffuse bleb. An aqueous jet at the limbus encour- TABLE 1. FEATURES OF THE SAFE SURGERY SYSTEM TO MINIMIZE COMPLICATIONS Prevent Hypotony Prevent Thin, Uncomfortable, Prevent Limbal Leaks of Aqueous Cystic Blebs New adjustable sutures for the scleral flap Large area of antimetabolite treatment Corneal groove-closure technique that can be gently titrated downward Continuous intraoperative infusion to Posterior diversion of aqueous by altering prevent intraoperative hypotony and scleral flap’s construction achieve accurate pressure titration Small sclerostomy punch Fornix-based flap to minimize posterior scarring Fornix-based conjunctival flap to opti- Bleb’s location under eyelid confirmed mize construction of the scleral flap MARCH/APRIL 2005 IGLAUCOMA TODAYI 23 SURGICAL PEARLS ages the formation of an anterior, focal cystic bleb. In preference is corneal shields rather than other sponges. contrast, a posteriorly directed, diffuse flow of aqueous Once cut in half and folded like a foldable lens (Figure 7A), from the incompletely cut sides of a large scleral flap the sponge fits through the entrance to the scleral pocket results in a more diffuse, noncystic bleb. We preplace without touching the conjunctival edges. Each sponge is sutures in the scleral flap while the eye is still firm, be- approximately 5 X 3 mm, and we insert about six of them cause suturing is more difficult after the eye has been into the pocket (Figure 7B). entered and is hypotonous. We treat as large an area as possible, including under the scleral flap. The polyvinyl alcohol sponges maintain their ANTIMETABOLITES integrity. In contrast, methylcellulose sponges fragment rela- Intraoperative Use tively easily, which increases the chance that small pieces of Our earlier article for Glaucoma Today3 covered patient sponge will remain in the wound. Enlarging the surface area risk factors for scarring, the risks of antimetabolite-related of treatment results in a more diffuse, noncystic area clini- complications, and our regimen with these agents. If intra- cally. It also prevents the development of the ring of steel, operative antimetabolites are indicated, we now use them which would otherwise restrict aqueous flow and promote after cutting the half-thickness scleral flap but before enter- the development of a raised, cystic, avascular bleb. ing the eye, because we have often found scar tissue in the subscleral space upon re-exploration. The other advantage Duration and Washout of Antimetabolite Treatment of cutting the flap first is that we can withhold antimetabo- We apply the antimetabolite for 3 minutes based on our lites if there is any problem with the scleral flap or scleral pharmacokinetic studies.5 If we need to vary the effect of integrity or any sign of aqueous’ leaking through the flap. MMC, we change its concentration but only use either 0.2 or 0.5 mg/mL. Alternatively, we apply 50 mg/mL of 5-fluo- Conjunctival Clamp rouracil intraoperatively and wash it out with 20 mL of BSS. We use a special conjunctival T clamp (Khaw Small Our pharmacokinetic experiments have shown a rapid Conjunctival Clamp, No. 2-686; Duckworth & Kent Ltd., uptake of the drug by the conjunctiva for 3 minutes during Hertfordshire, England) designed to hold back the conjunc- the application, after which the ocular tissue absorbs rela- tiva and to prevent exposing the cut edge of the conjuncti- tively little additional antimetabolite. In the period from 1 va to the antimetabolite. This clamp maintains a pocket for to 3 minutes, the dose delivered varies considerably, and antimetabolite treatment. Because our experiments have small, unavoidable inconsistencies in the time of delivery shown that the agent affects mainly the area it touches,4 cause a great variation in drug delivery. protecting the conjunctiva’s edge prevents wound leaks and dehiscence (Figure 6). Complication Rate An altered area of treatment (described earlier), our Type of Sponge aforementioned construction of conjunctival and scleral We use circular, medical grade, polyvinyl alcohol flaps, and our use of adjustable sutures (described later) sponges that are commonly employed during LASIK; our have dramatically reduced our incidence of short- and Figure 5. Limited side cuts to the scleral flap encourage the Figure 6. A special conjunctival T clamp holds tissue away posterior flow of aqueous. from the antimetabolite. 24 IGLAUCOMA TODAYIMARCH/APRIL 2005 SURGICAL PEARLS AB Figure 7. Polyvinyl alcohol sponges are folded (A) and inserted into the scleral pocket without touching the cut edge of conjunctiva (B). long-term complications. For example, the cystic areas imal chance of damaging the crystalline lens. Similarly, if we within the bleb have decreased from 90% to 29% (Fig- need to reform the anterior chamber intra- or postopera- ure 8). The rate of blebitis and endophthalmitis over 3 tively, we will introduce a cannula through an oblique para- to 5 years was 20% for older limbus-based techniques centesis and thereby minimize the chance of lenticular trau- with a smaller treatment area versus none during the ma. An inferiorly placed entry site will allow us access to the same period for the current technique.6 In 2004, Paul anterior chamber, if necessary, in the outpatient clinic. Palmberg, MD, of Miami told Dr. Khaw that his compli- cation rate also decreased in low-risk populations from INFUSION approximately 6% to 0.5%. If Dr. Palmberg’s and our sta- We use an anterior-segment infusion cannula (Lewicky; tistics were extrapolated to an approximate figure of Visitec Company, Sarasota, FL) on a three-way tap through 50,000 trabeculectomies with antimetabolites per year the paracentesis (Figure 10).
Recommended publications
  • Ocular Surface Changes Associated with Ophthalmic Surgery
    Journal of Clinical Medicine Review Ocular Surface Changes Associated with Ophthalmic Surgery Lina Mikalauskiene 1, Andrzej Grzybowski 2,3 and Reda Zemaitiene 1,* 1 Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, 44037 Kaunas, Lithuania; [email protected] 2 Department of Ophthalmology, University of Warmia and Mazury, 10719 Olsztyn, Poland; [email protected] 3 Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, 61553 Poznan, Poland * Correspondence: [email protected] Abstract: Dry eye disease causes ocular discomfort and visual disturbances. Older adults are at a higher risk of developing dry eye disease as well as needing for ophthalmic surgery. Anterior segment surgery may induce or worsen existing dry eye symptoms usually for a short-term period. Despite good visual outcomes, ocular surface dysfunction can significantly affect quality of life and, therefore, lower a patient’s satisfaction with ophthalmic surgery. Preoperative dry eye disease, factors during surgery and postoperative treatment may all contribute to ocular surface dysfunction and its severity. We reviewed relevant articles from 2010 through to 2021 using keywords “cataract surgery”, ”phacoemulsification”, ”refractive surgery”, ”trabeculectomy”, ”vitrectomy” in combina- tion with ”ocular surface dysfunction”, “dry eye disease”, and analyzed studies on dry eye disease pathophysiology and the impact of anterior segment surgery on the ocular surface. Keywords: dry eye disease; ocular surface dysfunction; cataract surgery; phacoemulsification; refractive surgery; trabeculectomy; vitrectomy Citation: Mikalauskiene, L.; Grzybowski, A.; Zemaitiene, R. Ocular Surface Changes Associated with Ophthalmic Surgery. J. Clin. 1. Introduction Med. 2021, 10, 1642. https://doi.org/ 10.3390/jcm10081642 Dry eye disease (DED) is a common condition, which usually causes discomfort, but it can also be an origin of ocular pain and visual disturbances.
    [Show full text]
  • Documentation Dissection
    Documentation Dissection Pre and Postoperative diagnosis: Uncontrolled moderate open angle glaucoma, left eye |1|. Procedure: Trabeculectomy of externo with peripheral iridectomy |2| Anesthesia: Conscious sedation, peribulbar block. Estimated blood loss: Less than 1 cc. COMPLICATIONS: None. The patient has had progressive visual field deterioration on maximum tolerated medications, and pressures in the high teens with a diagnosis of uncontrolled open angle glaucoma, left eye. To preserve her visual field, it was felt that surgery was necessarygiven the extensive damage to her optic nerve and field already existing |3|. The risks, benefits, and alternatives to surgery were discussed with the patient as well as with her husband, and she was anxious to proceed. PROCEDURE: The patient was brought to the operating room where she was given an intravenous sedative and peribulbar block. She was then prepped and draped in customary sterile fashion for intraocular surgery. A wire lid speculum was placed, and a 6-0 Vicryl traction suture was put through the superior peripheral cornea. The globe was retracted downward. The conjunctiva was entered 12 mm proximal to the limbus. With a combination of blunt and sharp dissection it was dissected down to the surgical limbus. The Gill’s knife was used to bare the limbus, and hemostasis was achieved with bipolar cautery |4|. A 4 x 4 mm rectangular lamellar flap was outlined with the 200 to 300 micron blade, |5| after which Mitomycin C 0.3 mg/cc was applied to the surface of the sclera overlying the outlying trap door for 2 minutes 30 seconds. The sponge and all instruments used to manipulate the Micomycin sponge were removed from the field, and the eye was vigorously irrigated with balanced salt solution (BSS).
    [Show full text]
  • Trabeculectomy Bleb Assessment Via Three-Dimensional Anterior Segment Optical Coherence Tomography
    Central JSM Ophthalmology Research Article *Corresponding author Takahiro Kawaji, Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Trabeculectomy Bleb Honjo, Chuo-ku, Kumamoto 860-8556, Japan, Tel: +81-96-373-5247; Fax: +81-96-373-5249; Email: Assessment via Three- Submitted: 23 February 2014 Accepted: 03 March 2014 dimensional Anterior Segment Published: 07 March 2014 ISSN: 2333-6447 Optical Coherence Tomography Copyright Takahiro Kawaji*, Toshihiro Inoue, Riyo Matsumura, Utako © 2014 Kawaji et al. Kuroda, Kei-Ichi Nakashima and Hidenobu Tanihara OPEN ACCESS Department of Ophthalmology, Kumamoto University, Japan Keywords Abstract • Glaucoma • Trabeculectomy Background: To evaluate the morphological features of filtering blebs after • Bleb trabeculectomy by using three-dimensional anterior segment optical coherence • Three-dimensional anterior segment optical tomography (3D AS-OCT). coherence tomography Methods: This retrospective cross-sectional study evaluated 47 patients who had undergone trabeculectomy with mitomycin C. All blebs were imaged with 3D AS-OCT and analyzed with our custom software. We assessed blebs quantitatively for the following features: bleb height, fluid-filled cavity height, bleb wall thickness, and bleb wall intensity. Results: The mean (± standard deviation [SD]) time period between trabeculectomy and 3D AS-OCT measurement was 9.5 ± 6.2 months; the mean (±SD) intraocular pressure (IOP) measured 14.0 ± 4.3 mm Hg at the time of 3D AS-OCT imaging. IOP and the bleb height (rs = -0.609, P = < .0001), the fluid-filled cavity height (rs = -0.381, P = 0.009), the bleb wall thickness (rs = -0.503, P = 0.0004) and the bleb wall intensity (rs = 0.612, P = < .0001) showed statistically significant correlations.
    [Show full text]
  • Effect of Trabeculotomy on Corneal Endothelial Cell Loss in Cases of After Penetrating-Keratoplasty Glaucoma
    CLINICAL SCIENCE Effect of Trabeculotomy on Corneal Endothelial Cell Loss in Cases of After Penetrating-Keratoplasty Glaucoma Ayaka Kusakabe, BS, MS,* Naoki Okumura, MD, PhD,* Koichi Wakimasu, MD,† Kanae Kayukawa, MD,† Masami Kondo, BS,* Noriko Koizumi, MD, PhD,* Chie Sotozono, MD, PhD,‡ Shigeru Kinoshita, MD, PhD,†‡§ and Kazuhiko Mori, MD, PhD‡ laucoma is recognized as one of the most devastating Purpose: The aim of this study was to evaluate the effect of Gcomplications that can arise after corneal transplantation, trabeculotomy (TLO) on glaucoma and endothelial cell loss after as it can often lead to corneal graft failure and glaucomatous penetrating keratoplasty (PK). optic neuropathy resulting in visual field loss. In 1969, Irvine 1 Methods: A retrospective study was conducted on consecutive patients and Kaufman reported a high incidence of intraocular who underwent PK and in whom more than 24 months of follow-up was pressure (IOP) elevation after penetrating keratoplasty (PK). available. Patients were categorized into the PK+TLO group [ie, TLO for Currently, it is widely accepted that the incidence of post-PK glaucoma (n = 10)] and the PK group [PK alone (n = 73)]. glaucoma after PK is high, ranging from 9% to 35% of all cases.2–8 Intraocular pressure (IOP) was evaluated during each follow-up fi examination. Central corneal endothelium images were obtained and Topical administration of antiglaucoma drugs is a rst- analyzed to determine corneal endothelial cell (CEC) density. line treatment for the control of IOP. However, as manage- ment of glaucoma after corneal transplantation is difficult, Results: The mean duration period from original PK to TLO for surgical treatments are often required.8 Trabeculectomy secondary glaucoma was 25.5 6 34.9 months in the PK+TLO group.
    [Show full text]
  • Glaucoma Management After Corneal Transplantation Surgeries
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Curr Opin Manuscript Author Ophthalmol. Manuscript Author manuscript; available in PMC 2017 September 05. Published in final edited form as: Curr Opin Ophthalmol. 2016 March ; 27(2): 132–139. doi:10.1097/ICU.0000000000000237. Glaucoma management after corneal transplantation surgeries Helen L. Kornmann and Steven J. Gedde Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA Abstract Purpose of review—Intraocular pressure (IOP) elevation and glaucoma progression following corneal transplantation, specifically, penetrating keratoplasty, Descemet’s stripping endothelial keratoplasty, and Boston keratoprosthesis, are well described causes of ocular morbidity. Depending on the procedure performed, the incidence of glaucoma is highly variable. Several etiologic factors have been identified, the most common being synechial angle closure and corticosteroid-induced IOP elevation. The purpose of this review is to describe the various treatment strategies for glaucoma following corneal transplantation. Recent findings—Medications and laser treatments are usually first-line therapies for postoperative IOP elevation. Surgical intervention, including filtering surgery and glaucoma drainage devices, may be necessary to control IOP and prevent progressive glaucomatous damage. Summary—Glaucoma is a common complication of corneal transplantation, and the degree of aggressiveness is often related to the indication for corneal surgery.
    [Show full text]
  • Primary Open Angle Glaucoma and Post-LASIK Keratectasia
    Challenging Case Primary Open Angle Glaucoma and Post-LASIK Keratectasia Section Editor: Mohammad Pakravan, MD mmHg in the right and left eyes respectively CASE PRESENTATION while receiving latanoprost (once daily), timolol The patient presented herein is a 52-year-old (twice daily) and dorzolamide (twice daily) woman suffering from primary open angle in both eyes. Central corneal thickness (CCT) glaucoma (POAG) in both eyes. She has no measured 431 and 322 microns in her right history of systemic disorders and is not on any and left eyes respectively. Fundus examination systemic medications. She underwent laser in situ revealed average-sized discs with vertical cup keratomileusis (LASIK) 9 years ago for refractive to disc ratios of 0.9 and 0.8 in the right and left error of -5.50-3.00×180 in both eyes, and was eyes respectively, together with inferior rim diagnosed with glaucoma 7 years afterwards. loss; the macula, vessels and periphery were Her ocular examination when I saw her for the unremarkable. Baseline automated perimetry first time two years ago was as follows. (Humphrey Field Analyzer II, Humphrey Best corrected visual acuity (BCVA) was Systems, Carl Zeiss Meditec Inc., Dublin, USA) 6/10 and 3/10 in the right and left eyes with is shown in figure 2. -4.00-1.00×30 and -13.00-5.50×180 respectively Considering that target IOP had been while wearing rigid gas permeable (RGP) contact achieved, I suggested that she be followed lenses. Slitlamp examination revealed a LASIK closely with medications. She was observed flap and signs of corneal ectasia in the left eye, for two years, but on her last examination I mild nuclear sclerosis changes were evident noticed suspicious progression of cupping and in both eyes and other slitlamp findings were visual field defects especially in her left eye.
    [Show full text]
  • Five-Year Outcomes of Trabeculectomy and Phacotrabeculectomy
    Open Access Original Article DOI: 10.7759/cureus.12950 Five-Year Outcomes of Trabeculectomy and Phacotrabeculectomy Danny Lam 1 , David Z. Wechsler 1, 2 1. Ophthalmology, University of Sydney, Sydney, AUS 2. Ophthalmology, Macquarie University, Sydney, AUS Corresponding author: Danny Lam, [email protected] Abstract Purpose The purpose of this study is to examine five-year outcomes of trabeculectomy and compare the stand-alone procedure when combined with phacoemulsification. Patients and methods This study included 123 eyes of 109 patients, with 79 patients in the trabeculectomy group and 44 patients in the phacotrabeculectomy group. Non-randomized comparative cohort study with data collected retrospectively from an existing database compiled by a single surgeon operating in Sydney, Australia from 2007 to 2019. The primary outcome measure was intraocular pressure. Secondary outcome measures were a number of glaucoma medications, treatment success rates, best-corrected visual acuity, bleb morphology, post-operative complications, and re-operation rate. Results The mean intraocular pressure was 10.6 ± 2.7 mm Hg in the trabeculectomy group (pre-operative mean intraocular pressure of 28.0 ± 9.8) and 12.0 ± 3.0 mm Hg in the phacotrabeculectomy group (pre-operative mean intraocular pressure of 23.4 ± 7.9) after five years (P = 0.052). The number of glaucoma medications required was 0.3 ± 0.7 in the trabeculectomy group (pre-operative mean of 3.7 ± 1.1) and 1.3 ± 1.2 in the phacotrabeculectomy group (pre-operative mean of 3.1 ± 1.0, P < 0.001). Conclusions Intraocular pressure reduction post-operatively over five years was similar between trabeculectomy and phacotrabeculectomy as determined by mean intraocular pressure, and intraocular pressure reduction from baseline.
    [Show full text]
  • Brochure on Trabeculectomy Surgery for Glaucoma
    Frequently asked questions Goodwood Eye Centre 1. Will I need to have Trabeculectomy surgery repeated? Many patients, about 80%, still have safe low eye pressure 4-5 years after the surgery. Many procedures will still be successful decades later. However about 20% of You will find more information about procedures fail to control the eye pressure Glaucoma through Glaucoma Australia during the first few years post surgery and www.glaucoma.org.au additional surgery will be required. 2. How long should I take off work/ sport/swimming etc You will need to take approximately 7-14 days off work, sport and swimming. Please discuss this with Dr Phipps. He can provide you with a sick certificate for this period. 3. When can I drive after Trabeculectomy? You will need to avoid driving for 7-14 days. Important Please discuss this with Dr Phipps. It is also recommended that you wear sunglasses information about during the day for the following week after Trabeculectomy you commence driving. surgery 4. Do I need someone with me? Goodwood Eye Centre Yes. You will need a support person to 186 Goodwood Road Millswood SA 5034 transport you from the day surgery after the P: 08 8377 7644 F: 08 8272 6575 procedure. You are advised to have someone E: [email protected] with you for the first 24 hours. www.goodwoodeyecentre.com.au What is Trabeculectomy Surgery Why do I need to have this procedure? What are the side effects? (Filtration Surgery) for Glaucoma? This surgery is performed to treat glaucoma. You may experience some redness, eye discomfort, The surgery creates a controlled outward flow It is recommended when medicine and laser blurry vision and sensitivity to bright light after of fluid from your eye by creating a drainage site treatments have failed to successfully reduce the the procedure for up to two to three weeks.
    [Show full text]
  • Phaco-Trabeculectomy Equals Trabeculectomy in Lowering IOP-A
    perim Ex en l & ta a l ic O p in l h t C h f Journal of Clinical & Experimental a o l m l a o n l r o Wachtl et al., J Clin Exp Ophthalmol 2016, 7:6 g u y o J Ophthalmology DOI: 10.4172/2155-9570.1000622 ISSN: 2155-9570 Research Article Open Access Phaco-Trabeculectomy Equals Trabeculectomy in Lowering IOP-A 4 Years Follow-Up Study Josephine Wachtl1,2, Marc Töteberg-Harms1, Sonja Frimmel1 and Christoph Kniestedt1,2* 1UniversityHospital Zurich, Department of Ophthalmology, Frauenklinikstrasse 24, 8091 Zurich, Switzerland 2Talacker Eye Center Zurich, TAZZ, Pelikanstrasse 18, 8001 Zurich, Switzerland *Corresponding author: Christoph Kniestedt, Department of Ophthalmology, UniversityHospital Zurich, Frauenklinikstrasse 24, 8091 Zurich, Switzerland, Tel: 41(44)2177721; Fax: 41(44)2177712; E-mail [email protected] Received date: December 12, 2015; Accepted date: December 29, 2016; Published date: December 30, 2016 Copyright: ©2016 Wachtl J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Objective: The aim of this study was to compare the long-term efficacy and safety of combined phaco- trabeculectomy (phaco-trab) and trabeculectomy (trab) alone. Methods: Retrospective, non-randomized, interventional case series of phaco-trab and trab. Inclusion criteria were diagnosis of glaucoma for both plus vision impairing coexisting cataracts for phaco-trab. Primary outcome measures were change in intraocular pressure (IOP) and number of anti-glaucoma drugs (AGD) at 1 y and 4 ys after surgery, and postoperative interventions (i.e.
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • Morphology of Trabeculectomy Filtering Blebs Using Anterior Segment Optical Coherence Tomography: a Comparison of Two Methods
    Morphology of Trabeculectomy Filtering Blebs using Anterior Segment Optical Coherence Tomography: A Comparison of Two Methods Rita Pinto Proença1, Joana Ferreira1,2 and João Paulo Cunha1,2 1Department of Ophthalmology, Central Lisbon Hospital Center, Lisbon, Portugal 2Nova Medical School, Universidade Nova de Lisboa, Lisbon, Portugal Keywords: Glaucoma, Imaging, Optical Coherence Tomography, Trabeculectomy, Filtering Blebs. Abstract: Anterior segment imaging optical coherence tomography (AS-OCT) can be a useful aid in glaucoma surgery. Recent studies have shown its importance in both the preoperative morphologic evaluation of glaucoma patients as well as postoperative evaluation of filtering bleb functionality. Our purpose is to evaluate post- trabeculectomy filtering and non-filtering bleb characteristics in both time-domain OCT (TD-OCT, Visante™, Carl Zeiss) and spectral-domain OCT (SD-OCT, Heidelberg Spectralis ® anterior segment module), assess the usefulness of AS-OCT in evaluating postoperative filtering bleb function and compare both methods results. AS-OCT as a useful exam in determining functioning and non-functioning bleb characteristics. SD-OCT with an anterior segment module had a better performance in examining fine bleb features and performed better than in previous studies in examining deeper structures. 1 INTRODUCTION depth data. Bleb imaging with OCT is useful as it is a non-contact imaging method, in contrast to Trabeculectomy has been performed for the treatment ultrasound biomicroscopy (Drexler W et al., 1999 and of
    [Show full text]
  • Simultaneous Bilateral Trabeculectomy
    SIMULTANEOUS BILATERAL TRABECULECTOMY C. E. HUGKULSTONE, L. STEVENSON and S. A. VERNON Nottingham SUMMARY further. We report here the results of the firststudy of sim­ In a retrospective study, 24 patients who had undergone ultaneous bilateral trabeculectomy. simultaneous bilateral trabeculectomy over a 6-year METHODS period were reviewed. The duration of disease was at least 2 years, indicating that surgery was not performed All patients who had undergone trabeculectomy between as a primary procedure. No patients suffered complica­ January 1985 and December 1990 were identified from tions leading to bilateral blindness, although 6 (25%) theatre records, and the case-notes of those who had had patients had reduced vision in both eyes at the first post­ simultaneous bilateral trabeculectomy were reviewed operative visit, with 3 (13%) worse than 6/36 binocularly. (group A). There was no evidence of an asymmetric response in the The following data were recorded: the sex of the patient fall in intraocular pressure following trabeculectomy, and age at the time of surgery, the glaucoma diagnosis and after a mean follow-up of over 3 years. Compared with a the duration of disease before admission. The intraocular matched group of patients undergoing unilateral trabe­ pressure (JOP) was noted for each eye at diagnosis, on culectomy, the simultaneous bilateral group had a similar admission, at the first post-operative visit and at 6 months, period of hospital stay. However, this was no shorter than 1 year and at the final visit, as were the number of ocular that found in a group having staged bilateral surgery hypotensive medications.
    [Show full text]